These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis? De Panfilis G, Ferrari D, Santoro S, Ricci R, Lombardi M, Pedrazzi G, Pepe C, Cortelazzi C, Santini M. Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173 [Abstract] [Full Text] [Related]
48. Epiluminescence microscopy features of cutaneous malignant melanoma metastases. Schulz H. Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382 [Abstract] [Full Text] [Related]
49. Report of 27 cases of naevus spilus in 2134 patients with melanoma: is naevus spilus a risk marker of cutaneous melanoma? Manganoni AM, Pavoni L, Farisoglio C, Sereni E, Calzavara-Pinton P. J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):129-30. PubMed ID: 22168780 [No Abstract] [Full Text] [Related]
50. [Surgical management of orbital malignant melanoma: our experience and a report of three cases]. Poli T, Mora P, Reichegger V, Ricci R, Corradi D, Gandolfi SA, Sesenna E. Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825 [Abstract] [Full Text] [Related]
52. Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature. Stierman SC, Tierney EP, Shwayder TA. Pediatr Dermatol; 2009 Oct; 26(4):414-24. PubMed ID: 19689516 [Abstract] [Full Text] [Related]
54. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Kölmel KF, Grange JM, Krone B, Mastrangelo G, Rossi CR, Henz BM, Seebacher C, Botev IN, Niin M, Lambert D, Shafir R, Kokoschka EM, Kleeberg UR, Gefeller O, Pfahlberg A. Eur J Cancer; 2005 Jan; 41(1):118-25. PubMed ID: 15617996 [Abstract] [Full Text] [Related]
55. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment? Moretti S, Spallanzani A, Pinzi C, Prignano F, Fabbri P. J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800 [Abstract] [Full Text] [Related]
57. [Melanoma in organ transplant patients]. Lévêque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B, Hazan M, Schollhamer M, Aubin F, Dreno B, Daguin P, Chevrant-Breton J, Frances C, Bismuth MJ, Tanter Y, Lambert D. Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973 [Abstract] [Full Text] [Related]
58. [The controversial aspects in malignant cutaneous melanoma]. Ordóñez Gallego A, Feliu Batlle J, González Barón M. Med Clin (Barc); 1993 Jun 12; 101(3):110-4. PubMed ID: 8315982 [No Abstract] [Full Text] [Related]
59. Vitiligo and malignant melanoma. Fodor J, Bodrogi I. Neoplasma; 1975 Jun 12; 22(4):445-8. PubMed ID: 1196428 [Abstract] [Full Text] [Related]
60. Malignant melanoma in a case of bilateral nevus of Ota. Halasa A. Arch Ophthalmol; 1970 Aug 12; 84(2):176-8. PubMed ID: 5449636 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]